Lewen Bao
State Key Laboratory Of Cancer Prevention And Therapy Of Tianjin
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-World Experience of Niraparib as Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian Cancer: A Single-Center Retrospective Study.
Journal: OncoTargets and therapy
Published: May 20, 2025
Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study.
Journal: Signal transduction and targeted therapy
Published: October 28, 2024
Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition.
Journal: Frontiers in immunology
Published: November 16, 2018
LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214.
Journal: Cancer biology & medicine
Published: September 11, 2018
Opportunistic salpingectomy at benign gynecological surgery for reducing ovarian cancer risk: a 10-year single centre experience from China and a literature review.
Journal: Journal of Cancer
Published: May 26, 2017
Phenethyl isothiocyanate suppresses cervical carcinoma metastasis potential and its molecular mechanism.
Journal: Molecular medicine reports
Published: December 02, 2013
Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk.
Journal: International journal of molecular sciences
Published: February 16, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026